Meningeal Inflammation on 7T MRI as a Tool for Measuring and Predicting Ocrelizumab Response in Multiple Sclerosis
Clinical trial NCT03396822 · COMPLETED
Trial details
- NCT number
- NCT03396822
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-24
- Primary completion
- 2023-05-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.